Advancing vaccine development through green biotechnology

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

July 11, 2023

Cybin Launches Renewed ATM Equity Program Up To $35M

Psychedelics biotech Cybin Inc. CYBN announced it has renewed its previously established at-the-market (ATM) equity program allowing the company to gradually issue and sell up to $35 million in common shares

August 25, 2023

Blood Test Detects Alzheimer’s Pathology in Other Clinical Syndromes

Plasma p-tau217 successfully identified Alzheimer’s pathology in several neurodegenerative syndromes. This included disorders not typically associated with Alzheimer’s disease, like frontotemporal dementia. Alzheimer’s pathology in

February 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.